Correspondence 0001104659-24-089047 from Replimune Group, Inc. (REPL) (CIK 0001737953) (REPL)
Replimune Group, Inc. (REPL) (CIK 0001737953)
Date: Aug. 13, 2024 · CIK: 0001737953 · Accession: 0001104659-24-089047
AI Filing Summary & Sentiment
File numbers found in text: 333-281358
Show Raw Text
CORRESP
1
filename1.htm
Replimune Group, Inc.
500 Unicorn Park Drive,
Suite 303
Woburn, MA 01801
August 13, 2024
VIA EDGAR SUBMISSION AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: Daniel Crawford
Re:
Replimune Group, Inc. Registration Statement on Form S-3 Filed August 8, 2024 (Registration No. 333-281358)
Dear Mr. Crawford:
In accordance with Rule 461
of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration
of the effective date of the above-referenced Registration Statement (the “Registration Statement”) of Replimune
Group, Inc. We respectfully request that the Registration Statement become effective as of 4:05 p.m., Eastern time, on August 14,
2024, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event
with our counsel, Morgan, Lewis & Bockius LLP, by calling Benjamin J. Stein at (617) 341-7775.
[Remainder of page intentionally left blank]
Very truly yours,
Replimune Group, Inc.
By:
/s/ Shawn Glidden
Shawn Glidden
General Counsel
cc:
Sushil Patel, Replimune Group, Inc.
Timothy J. Corbett, Morgan, Lewis & Bockius LLP